CD274 and cancer: In view of the finding that the BRD4/IRS2 inhibitor cocktail downregulates the expression of PD‐L1 in melanoma cells, we propose that these inhibitors may represent an additional approach to reduce the expression of PD‐L1 in cancer cells.